List of Tables
Table 1. Global Digital Therapeutics Platforms Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Digital Therapeutics Platforms Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Digital Therapeutics Platforms Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Digital Therapeutics Platforms Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Digital Therapeutics Platforms Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Digital Therapeutics Platforms Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Digital Therapeutics Platforms Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Digital Therapeutics Platforms by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics Platforms as of 2024)
Table 11. Global Digital Therapeutics Platforms Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Digital Therapeutics Platforms Companies Headquarters
Table 13. Global Digital Therapeutics Platforms Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Digital Therapeutics Platforms Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Digital Therapeutics Platforms Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Digital Therapeutics Platforms Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Digital Therapeutics Platforms Revenue by Application (2026-2031) & (US$ Million)
Table 21. Digital Therapeutics Platforms High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Digital Therapeutics Platforms Growth Accelerators and Market Barriers
Table 25. North America Digital Therapeutics Platforms Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Digital Therapeutics Platforms Growth Accelerators and Market Barriers
Table 27. Europe Digital Therapeutics Platforms Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Digital Therapeutics Platforms Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Digital Therapeutics Platforms Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Digital Therapeutics Platforms Investment Opportunities and Key Challenges
Table 31. Central and South America Digital Therapeutics Platforms Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Digital Therapeutics Platforms Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Digital Therapeutics Platforms Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Akili Interactive Corporation Information
Table 35. Akili Interactive Description and Major Businesses
Table 36. Akili Interactive Product Features and Attributes
Table 37. Akili Interactive Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Akili Interactive Revenue Proportion by Product in 2024
Table 39. Akili Interactive Revenue Proportion by Application in 2024
Table 40. Akili Interactive Revenue Proportion by Geographic Area in 2024
Table 41. Akili Interactive Digital Therapeutics Platforms SWOT Analysis
Table 42. Akili Interactive Recent Developments
Table 43. DarioHealth Corporation Information
Table 44. DarioHealth Description and Major Businesses
Table 45. DarioHealth Product Features and Attributes
Table 46. DarioHealth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. DarioHealth Revenue Proportion by Product in 2024
Table 48. DarioHealth Revenue Proportion by Application in 2024
Table 49. DarioHealth Revenue Proportion by Geographic Area in 2024
Table 50. DarioHealth Digital Therapeutics Platforms SWOT Analysis
Table 51. DarioHealth Recent Developments
Table 52. Teladoc Health Corporation Information
Table 53. Teladoc Health Description and Major Businesses
Table 54. Teladoc Health Product Features and Attributes
Table 55. Teladoc Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Teladoc Health Revenue Proportion by Product in 2024
Table 57. Teladoc Health Revenue Proportion by Application in 2024
Table 58. Teladoc Health Revenue Proportion by Geographic Area in 2024
Table 59. Teladoc Health Digital Therapeutics Platforms SWOT Analysis
Table 60. Teladoc Health Recent Developments
Table 61. Voluntis Corporation Information
Table 62. Voluntis Description and Major Businesses
Table 63. Voluntis Product Features and Attributes
Table 64. Voluntis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Voluntis Revenue Proportion by Product in 2024
Table 66. Voluntis Revenue Proportion by Application in 2024
Table 67. Voluntis Revenue Proportion by Geographic Area in 2024
Table 68. Voluntis Digital Therapeutics Platforms SWOT Analysis
Table 69. Voluntis Recent Developments
Table 70. Sidekick Health Corporation Information
Table 71. Sidekick Health Description and Major Businesses
Table 72. Sidekick Health Product Features and Attributes
Table 73. Sidekick Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Sidekick Health Revenue Proportion by Product in 2024
Table 75. Sidekick Health Revenue Proportion by Application in 2024
Table 76. Sidekick Health Revenue Proportion by Geographic Area in 2024
Table 77. Sidekick Health Digital Therapeutics Platforms SWOT Analysis
Table 78. Sidekick Health Recent Developments
Table 79. WellDoc Corporation Information
Table 80. WellDoc Description and Major Businesses
Table 81. WellDoc Product Features and Attributes
Table 82. WellDoc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. WellDoc Recent Developments
Table 84. Talkspace Corporation Information
Table 85. Talkspace Description and Major Businesses
Table 86. Talkspace Product Features and Attributes
Table 87. Talkspace Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Talkspace Recent Developments
Table 89. CogniFit Corporation Information
Table 90. CogniFit Description and Major Businesses
Table 91. CogniFit Product Features and Attributes
Table 92. CogniFit Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. CogniFit Recent Developments
Table 94. Tata Elxsi Corporation Information
Table 95. Tata Elxsi Description and Major Businesses
Table 96. Tata Elxsi Product Features and Attributes
Table 97. Tata Elxsi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Tata Elxsi Recent Developments
Table 99. Mahalo Health Corporation Information
Table 100. Mahalo Health Description and Major Businesses
Table 101. Mahalo Health Product Features and Attributes
Table 102. Mahalo Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Mahalo Health Recent Developments
Table 104. 2Morrow Corporation Information
Table 105. 2Morrow Description and Major Businesses
Table 106. 2Morrow Product Features and Attributes
Table 107. 2Morrow Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. 2Morrow Recent Developments
Table 109. Omada Health Corporation Information
Table 110. Omada Health Description and Major Businesses
Table 111. Omada Health Product Features and Attributes
Table 112. Omada Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Omada Health Recent Developments
Table 114. Click Therapeutics Corporation Information
Table 115. Click Therapeutics Description and Major Businesses
Table 116. Click Therapeutics Product Features and Attributes
Table 117. Click Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Click Therapeutics Recent Developments
Table 119. Orexo Corporation Information
Table 120. Orexo Description and Major Businesses
Table 121. Orexo Product Features and Attributes
Table 122. Orexo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Orexo Recent Developments
Table 124. ResMed Corporation Information
Table 125. ResMed Description and Major Businesses
Table 126. ResMed Product Features and Attributes
Table 127. ResMed Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. ResMed Recent Developments
Table 129. Virta Health Corporation Information
Table 130. Virta Health Description and Major Businesses
Table 131. Virta Health Product Features and Attributes
Table 132. Virta Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Virta Health Recent Developments
Table 134. Bifourmis Corporation Information
Table 135. Bifourmis Description and Major Businesses
Table 136. Bifourmis Product Features and Attributes
Table 137. Bifourmis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Bifourmis Recent Developments
Table 139. SilverCloud (Amwell) Corporation Information
Table 140. SilverCloud (Amwell) Description and Major Businesses
Table 141. SilverCloud (Amwell) Product Features and Attributes
Table 142. SilverCloud (Amwell) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. SilverCloud (Amwell) Recent Developments
Table 144. Noom Corporation Information
Table 145. Noom Description and Major Businesses
Table 146. Noom Product Features and Attributes
Table 147. Noom Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Noom Recent Developments
Table 149. Big Health Corporation Information
Table 150. Big Health Description and Major Businesses
Table 151. Big Health Product Features and Attributes
Table 152. Big Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Big Health Recent Developments
Table 154. Kaia Health Corporation Information
Table 155. Kaia Health Description and Major Businesses
Table 156. Kaia Health Product Features and Attributes
Table 157. Kaia Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. Kaia Health Recent Developments
Table 159. Cognoa Corporation Information
Table 160. Cognoa Description and Major Businesses
Table 161. Cognoa Product Features and Attributes
Table 162. Cognoa Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. Cognoa Recent Developments
Table 164. Headspace Health Corporation Information
Table 165. Headspace Health Description and Major Businesses
Table 166. Headspace Health Product Features and Attributes
Table 167. Headspace Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. Headspace Health Recent Developments
Table 169. CureApp Corporation Information
Table 170. CureApp Description and Major Businesses
Table 171. CureApp Product Features and Attributes
Table 172. CureApp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. CureApp Recent Developments
Table 174. Calm Health Corporation Information
Table 175. Calm Health Description and Major Businesses
Table 176. Calm Health Product Features and Attributes
Table 177. Calm Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. Calm Health Recent Developments
Table 179. Riva Health Corporation Information
Table 180. Riva Health Description and Major Businesses
Table 181. Riva Health Product Features and Attributes
Table 182. Riva Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Riva Health Recent Developments
Table 184. Sweetch-Health Corporation Information
Table 185. Sweetch-Health Description and Major Businesses
Table 186. Sweetch-Health Product Features and Attributes
Table 187. Sweetch-Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 188. Sweetch-Health Recent Developments
Table 189. Lark Health Corporation Information
Table 190. Lark Health Description and Major Businesses
Table 191. Lark Health Product Features and Attributes
Table 192. Lark Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 193. Lark Health Recent Developments
Table 194. Vida Health Corporation Information
Table 195. Vida Health Description and Major Businesses
Table 196. Vida Health Product Features and Attributes
Table 197. Vida Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 198. Vida Health Recent Developments
Table 199. Mahana Therapeutics Corporation Information
Table 200. Mahana Therapeutics Description and Major Businesses
Table 201. Mahana Therapeutics Product Features and Attributes
Table 202. Mahana Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 203. Mahana Therapeutics Recent Developments
Table 204. Blue Note Therapeutics Corporation Information
Table 205. Blue Note Therapeutics Description and Major Businesses
Table 206. Blue Note Therapeutics Product Features and Attributes
Table 207. Blue Note Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 208. Blue Note Therapeutics Recent Developments
Table 209. Lyra Health Corporation Information
Table 210. Lyra Health Description and Major Businesses
Table 211. Lyra Health Product Features and Attributes
Table 212. Lyra Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 213. Lyra Health Recent Developments
Table 214. Modern Health Corporation Information
Table 215. Modern Health Description and Major Businesses
Table 216. Modern Health Product Features and Attributes
Table 217. Modern Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 218. Modern Health Recent Developments
Table 219. Canary Health Corporation Information
Table 220. Canary Health Description and Major Businesses
Table 221. Canary Health Product Features and Attributes
Table 222. Canary Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 223. Canary Health Recent Developments
Table 224. Virgin Pulse Corporation Information
Table 225. Virgin Pulse Description and Major Businesses
Table 226. Virgin Pulse Product Features and Attributes
Table 227. Virgin Pulse Revenue (US$ Million) and Gross Margin (2020-2025)
Table 228. Virgin Pulse Recent Developments
Table 229. Slanhealth Corporation Information
Table 230. Slanhealth Description and Major Businesses
Table 231. Slanhealth Product Features and Attributes
Table 232. Slanhealth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 233. Slanhealth Recent Developments
Table 234. Best Covered Corporation Information
Table 235. Best Covered Description and Major Businesses
Table 236. Best Covered Product Features and Attributes
Table 237. Best Covered Revenue (US$ Million) and Gross Margin (2020-2025)
Table 238. Best Covered Recent Developments
Table 239. Dami and Xiaomi Corporation Information
Table 240. Dami and Xiaomi Description and Major Businesses
Table 241. Dami and Xiaomi Product Features and Attributes
Table 242. Dami and Xiaomi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 243. Dami and Xiaomi Recent Developments
Table 244. WeiMai Corporation Information
Table 245. WeiMai Description and Major Businesses
Table 246. WeiMai Product Features and Attributes
Table 247. WeiMai Revenue (US$ Million) and Gross Margin (2020-2025)
Table 248. WeiMai Recent Developments
Table 249. Jianhai Tech Corporation Information
Table 250. Jianhai Tech Description and Major Businesses
Table 251. Jianhai Tech Product Features and Attributes
Table 252. Jianhai Tech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 253. Jianhai Tech Recent Developments
Table 254. Raw Materials Key Suppliers
Table 255. Distributors List
Table 256. Market Trends and Market Evolution
Table 257. Market Drivers and Opportunities
Table 258. Market Challenges, Risks, and Restraints
Table 259. Research Programs/Design for This Report
Table 260. Key Data Information from Secondary Sources
Table 261. Key Data Information from Primary Sources
List of Figures
Figure 1. Digital Therapeutics Platforms Product Picture
Figure 2. Global Digital Therapeutics Platforms Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Chronic Disease Digital Therapeutics Product Picture
Figure 4. Psychiatric Disorders Digital Therapeutics Product Picture
Figure 5. Quit Smoking Digital Therapeutics Product Picture
Figure 6. Sleep Disorders and Respiratory Diseases Digital Therapeutics Product Picture
Figure 7. Others Product Picture
Figure 8. Global Digital Therapeutics Platforms Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Enterprise
Figure 10. Personal
Figure 11. Digital Therapeutics Platforms Report Years Considered
Figure 12. Global Digital Therapeutics Platforms Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 14. Global Digital Therapeutics Platforms Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Digital Therapeutics Platforms Revenue Market Share by Region (2020-2031)
Figure 16. Global Digital Therapeutics Platforms Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. Chronic Disease Digital Therapeutics Revenue Market Share by Player in 2024
Figure 19. Psychiatric Disorders Digital Therapeutics Revenue Market Share by Player in 2024
Figure 20. Quit Smoking Digital Therapeutics Revenue Market Share by Player in 2024
Figure 21. Sleep Disorders and Respiratory Diseases Digital Therapeutics Revenue Market Share by Player in 2024
Figure 22. Others Revenue Market Share by Player in 2024
Figure 23. Global Digital Therapeutics Platforms Revenue Market Share by Type (2020-2031)
Figure 24. Global Digital Therapeutics Platforms Revenue Market Share by Application (2020-2031)
Figure 25. North America Digital Therapeutics Platforms Revenue YoY (2020-2031) & (US$ Million)
Figure 26. North America Top 5 Players Digital Therapeutics Platforms Revenue (US$ Million) in 2024
Figure 27. North America Digital Therapeutics Platforms Revenue (US$ Million) by Type (2020 - 2031)
Figure 28. North America Digital Therapeutics Platforms Revenue (US$ Million) by Application (2020-2031)
Figure 29. US Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 30. Canada Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 31. Mexico Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 32. Europe Digital Therapeutics Platforms Revenue YoY (2020-2031) & (US$ Million)
Figure 33. Europe Top 5 Players Digital Therapeutics Platforms Revenue (US$ Million) in 2024
Figure 34. Europe Digital Therapeutics Platforms Revenue (US$ Million) by Type (2020-2031)
Figure 35. Europe Digital Therapeutics Platforms Revenue (US$ Million) by Application (2020-2031)
Figure 36. Germany Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 37. France Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 38. U.K. Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 39. Italy Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 40. Russia Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Digital Therapeutics Platforms Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Top 8 Players Digital Therapeutics Platforms Revenue (US$ Million) in 2024
Figure 43. Asia-Pacific Digital Therapeutics Platforms Revenue (US$ Million) by Type (2020-2031)
Figure 44. Asia-Pacific Digital Therapeutics Platforms Revenue (US$ Million) by Application (2020-2031)
Figure 45. Indonesia Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 46. Japan Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 47. South Korea Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 48. Australia Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 49. India Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 50. Indonesia Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 51. Vietnam Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 52. Malaysia Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 53. Philippines Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 54. Singapore Digital Therapeutics Platforms Revenue (2020-2031) & (US$ Million)
Figure 55. Central and South America Digital Therapeutics Platforms Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Central and South America Top 5 Players Digital Therapeutics Platforms Revenue (US$ Million) in 2024
Figure 57. Central and South America Digital Therapeutics Platforms Revenue (US$ Million) by Type (2020-2031)
Figure 58. Central and South America Digital Therapeutics Platforms Revenue (US$ Million) by Application (2020-2031)
Figure 59. Brazil Digital Therapeutics Platforms Revenue (2020-2025) & (US$ Million)
Figure 60. Argentina Digital Therapeutics Platforms Revenue (2020-2025) & (US$ Million)
Figure 61. Middle East and Africa Digital Therapeutics Platforms Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Middle East and Africa Top 5 Players Digital Therapeutics Platforms Revenue (US$ Million) in 2024
Figure 63. South America Digital Therapeutics Platforms Revenue (US$ Million) by Type (2020-2031)
Figure 64. Middle East and Africa Digital Therapeutics Platforms Revenue (US$ Million) by Application (2020-2031)
Figure 65. GCC Countries Digital Therapeutics Platforms Revenue (2020-2025) & (US$ Million)
Figure 66. Israel Digital Therapeutics Platforms Revenue (2020-2025) & (US$ Million)
Figure 67. Egypt Digital Therapeutics Platforms Revenue (2020-2025) & (US$ Million)
Figure 68. South Africa Digital Therapeutics Platforms Revenue (2020-2025) & (US$ Million)
Figure 69. Digital Therapeutics Platforms Industry Chain Mapping
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
